NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

Great. Thank you. There might be a possibility that after the patent is allowed that Merck could step forward with financial backing of some sort as partnering on the further Keytuda combo trials footing the bills and possibly paying upfront and milestone payments with % royalties.
In my experience the big moves in these types of biotech in this type of situation happen before TLD of the pivotal trials.
I call this the "Market Accepance Theory"
When this happens the company is revalued by the Market and the stock can 10x in just a few weeks. A partnership with Merck would do just that. The influx of upfront cash might allow up listing to major exchange. Subsequently NWBO could finish with the TLD and Publication but the Journal would be not as necessary as the Merck would lend a tremendous amount of credibility to NWBO. This would be one of the best ways to realize the fair market value of NWBO shares and allow the Institutions to get in early at $5-10 BEFORE TLD.